Literature DB >> 10737434

HIV-1 diversity in Brazil: genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. Brazilian Network for HIV Isolation and Characterization.

V Bongertz1, D C Bou-Habib, L F Brígido, M Caseiro, P J Chequer, J C Couto-Fernandez, P C Ferreira, B Galvão-Castro, D Greco, M L Guimarães, M I Linhares de Carvalho, M G Morgado, C A Oliveira, S Osmanov, C A Ramos, M Rossini, E Sabino, A Tanuri, M Ueda.   

Abstract

The Brazilian Network for HIV Isolation and Characterization was established for the surveillance of HIV variability in Brazil. Here, we report characterization of HIV strains and virus-specific immune responses from 35 clinical samples collected from three potential HIV vaccine sites. Three genetic subtypes of HIV-1 were identified by heteroduplex mobility assay (HMA) B (in 82.9% of the samples), F (14.3%), and C (2.9%). Phylogenetic analysis based on the C2V3/env DNA sequence from all 25 specimens examined was 100% concordant with HMA results. Four variants of subtype B with different tetrapeptides at the tip of the V3 loop were found: the GPGR motif (North American), GWGR motif (Brazilian B"), and two minor variants, GFGR and GPGS, as previously detected. No significant association was found between HIV-1 subtypes and the mode of transmission or biologic properties of HIV-1 isolates (derived from 88.6% of the specimens). Only 5 of 16 isolates studied were neutralized by the autologous sera. Consistent with previous results, no relation between viral subtype and peptide enzyme-linked immunosorbent assay (ELISA) seroreactivity or neutralization was evident. This study also demonstrated the effectiveness of the collaborative approach followed by Brazilian scientists when addressing a complex subject such as HIV variability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737434     DOI: 10.1097/00126334-200002010-00011

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  18 in total

1.  Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.

Authors:  Jan Felix Drexler; Luciano Kleber de Souza Luna; Celia Pedroso; Diana Brasil Pedral-Sampaio; Artur T L Queiroz; Carlos Brites; Eduardo M Netto; Christian Drosten
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

2.  Diagnostic detection of human immunodeficiency virus type 1 antibodies in urine: a brazilian study.

Authors:  Walter M R Oelemann; Catherine M Lowndes; Giovani C Veríssimo Da Costa; Mariza G Morgado; Luiz Roberto R Castello-Branco; Beatriz Grinsztejn; Michel Alary; Francisco I Bastos
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Comprehensive Characterization of HIV-1 Molecular Epidemiology and Demographic History in the Brazilian Region Most Heavily Affected by AIDS.

Authors:  Tiago Gräf; Hegger Machado Fritsch; Rúbia Marília de Medeiros; Dennis Maletich Junqueira; Sabrina Esteves de Matos Almeida; Aguinaldo Roberto Pinto
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

4.  Molecular epidemiology of HIV-1 clades in Southern Brazil.

Authors:  Sonia Mara Raboni; Sérgio Monteiro de Almeida; Indianara Rotta; Cléa Elisa Lopes Ribeiro; Debra Rosario; Luine Rosele Vidal; Meri Bordignon Nogueira; Maristela Riedel; Maria da Graça Winhescki; Kátia Antunes Ferreira; Ronald Ellis
Journal:  Mem Inst Oswaldo Cruz       Date:  2010-12       Impact factor: 2.743

5.  Rate and incidence estimates of recent human immunodeficiency virus type 1 infections among pregnant women in Sao Paulo, Brazil, from 1991 to 2002.

Authors:  Carmem A de Freitas Oliveira; Mirthes Ueda; Rosemeire Yamashiro; Rosângela Rodrigues; Haynes W Sheppard; Luís Fernando de Macedo Brígido
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

6.  In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms.

Authors:  Miguel E Quiñones-Mateu; Yong Gao; Sarah C Ball; Andre J Marozsan; Awet Abraha; Eric J Arts
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Inhibition of HIV-1 infection by monoclonal antibodies to carbohydrates of Schistosoma mansoni.

Authors:  Marco Antônio Gomes Mello; Rita Elizabeth Mascarenhas; Geraldo Argolo Ferraro; Donald Harn; Marco Galvão-Castro; Dumith Chequer Bou-Habib
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

8.  Prevalence of human immunodeficiency virus drug resistance mutations and subtypes in drug-naive, infected individuals in the army health service of Rio de Janeiro, Brazil.

Authors:  Ivone L Pires; Marcelo A Soares; Francisco A B Speranza; Solange K Ishii; Maria C G Vieira; Maria I F S Gouvêa; Maria A A M Guimarães; Fátima E de Oliveira; Monica M F Magnanini; Rodrigo M Brindeiro; Amilcar Tanuri
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

9.  Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India.

Authors:  Nagadenahalli B Siddappa; Prashanta K Dash; Anita Mahadevan; Narayana Jayasuryan; Fen Hu; Bethany Dice; Randy Keefe; Kadappa S Satish; Bhuthiah Satish; Kuttan Sreekanthan; Ramdas Chatterjee; Kandala Venu; Parthasarathy Satishchandra; Vasanthapuram Ravi; Susarla K Shankar; Raj Shankarappa; Udaykumar Ranga
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

10.  Near full-length genome analysis of low prevalent human immunodeficiency virus type 1 subclade F1 in São Paulo, Brazil.

Authors:  Sabri Saeed Sanabani; Evelyn Regina de Souza Pastena; Walter Kleine Neto; Claudia C Barreto; Kelly T Ferrari; Erika M N Kalmar; Suzete Ferreira; Ester Cerdeira Sabino
Journal:  Virol J       Date:  2009-06-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.